Zimmer Biomet Expects 2024 Adjusted Diluted EPS Of $8.00-$8.15 Versus Consensus Of $7.95, With Revenue Growth Of 4.5%-5.5% (5.0%-6.0% On Constant Currency)
Portfolio Pulse from Benzinga Newsdesk
Zimmer Biomet projects its 2024 adjusted diluted EPS to be between $8.00 and $8.15, surpassing the consensus estimate of $7.95. The company also forecasts revenue growth of 4.5%-5.5%, or 5.0%-6.0% on a constant currency basis.
February 08, 2024 | 11:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zimmer Biomet's 2024 earnings and revenue growth projections exceed market expectations, indicating a positive outlook for the company.
Zimmer Biomet's projection of a higher-than-expected EPS for 2024, along with its anticipated revenue growth, suggests strong future performance. This positive outlook is likely to instill confidence in investors, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100